FUSCO, ALFREDO
 Distribuzione geografica
Continente #
NA - Nord America 7.639
EU - Europa 3.895
AS - Asia 1.314
AF - Africa 71
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 12.928
Nazione #
US - Stati Uniti d'America 7.460
CN - Cina 1.111
IT - Italia 897
UA - Ucraina 709
IE - Irlanda 629
FI - Finlandia 524
SE - Svezia 365
DE - Germania 303
NL - Olanda 302
CA - Canada 177
GB - Regno Unito 119
VN - Vietnam 77
CI - Costa d'Avorio 71
IN - India 41
IR - Iran 30
FR - Francia 24
HK - Hong Kong 15
SG - Singapore 15
TR - Turchia 7
ES - Italia 5
JP - Giappone 5
BR - Brasile 4
PH - Filippine 4
BE - Belgio 3
CZ - Repubblica Ceca 3
RO - Romania 3
BG - Bulgaria 2
EU - Europa 2
KR - Corea 2
MX - Messico 2
TW - Taiwan 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
KZ - Kazakistan 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 12.928
Città #
Chandler 1.581
Jacksonville 832
Princeton 531
Millbury 506
Nanjing 370
Woodbridge 326
Amsterdam 294
Ashburn 282
Wilmington 243
Boston 230
Naples 171
Ottawa 169
Beijing 156
Napoli 148
Nanchang 141
Ann Arbor 132
Houston 128
Shenyang 88
Des Moines 80
Hebei 77
Dong Ket 76
Falls Church 76
Norwalk 73
Kronberg 65
Jiaxing 59
Tianjin 59
Boardman 56
Dublin 54
Kunming 45
Cagliari 42
Changsha 42
Aversa 31
Indiana 31
San Mateo 31
Washington 30
Lawrence 25
Augusta 23
Hangzhou 20
Los Angeles 18
Leawood 17
New York 17
Ardabil 15
Hong Kong 15
Caserta 14
Orange 14
Pune 12
Seattle 12
Shanghai 12
Pozzuoli 11
Changchun 10
Redmond 10
Tehran 10
Lanzhou 8
Mountain View 8
Tappahannock 8
Toronto 8
Formia 7
Monmouth Junction 7
Rome 7
Dearborn 6
Fairfield 6
Redwood City 6
Torino 6
Hanover 5
Jinan 5
San Francisco 5
Simi Valley 5
Singapore 5
Apex 4
Arienzo 4
Buffalo 4
Caivano 4
Castellammare di Stabia 4
General Trias 4
Little Rock 4
Marano Di Napoli 4
Mumbai 4
New Delhi 4
Salerno 4
Zhengzhou 4
Afragola 3
Benevento 3
Cambridge 3
Cercola 3
Fremont 3
Gijón 3
Guangzhou 3
Helsinki 3
Lissone 3
Marseille 3
Miami 3
Milan 3
Nocera Superiore 3
Serra 3
Yellow Springs 3
Anzio 2
Apo 2
Asahikawa 2
Bagnoli Irpino 2
Campora 2
Totale 7.715
Nome #
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation. 70
Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes. 69
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity 67
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas 67
HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. 65
HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. 65
High mobility group A1 protein modulates autophagy in cancer cells. 64
A ceRNA circuitry involving the long noncoding RNA Klhl14-AS, Pax8 and Bcl2 drives thyroid carcinogenesis 64
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients 63
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 59
A differential proteomic approach to identify proteins associated with thyroid cell transformation. 58
IFN-gamma gene expression is controlled by the architectural transcription factor HMGA1. 58
A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor 58
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs 55
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. 55
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. 55
The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration 55
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase 54
Expression, purification, and characterization of rat protein tyrosine phosphatase eta catalytic domain. 53
20 years of RET/PTC in thyroid cancer: clinico-pathological correlations. 53
Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy. 52
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. 52
CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression 52
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). 51
Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 51
TRANSCRIPTIONAL PROFILE OF KI-RAS-INDUCED TRANSFORMATION OF THYROID CELLS. 51
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 51
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 51
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma 51
Familial cancer associated with a polymorphism in ARLTS1. 50
HMGA1 overexpression is associated with a particular subset of human breast carcinomas 50
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 50
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 49
45th Annual Meeting of the Italian Cancer Society 49
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. 49
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 48
Hmga2 is necessary for Otx2-dependent exit of embryonic stem cells from the pluripotent ground state 48
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 48
UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. 47
Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. 47
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 47
HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells 47
Identification of a chimeric gene frequently activated in human thyroid papillary carcinomas 46
Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas 46
Differential HMGA expression and post-translational modifications in prostatic tumor cells. 45
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. 45
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. 45
Roles of HMGA proteins in cancer. 45
A new mechanism of BRAF activation in human thyroid papillary carcinomas 45
Association between the expression of E1 A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells 44
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 44
UbcH10 expression in human lymphomas. 44
Role of Dicer1 in thyroid cell proliferation and differentiation 44
High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. 43
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. 43
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 43
DNA damage, homology-directed repair, and DNA methylation. 43
Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype 43
Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. 42
Activated ret oncogene products induce maturation-promoting factor activation in Xenopus oocytes. 42
Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. 42
Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity 42
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 42
Neoplastic transformation of rat thyroid cells requires the JunB and Fra1 gene induction which is dependent on the HMGI-C gene products. 41
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas. 41
Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer. 41
UbcH10 is overexpressed in malignant breast carcinomas. 41
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells 41
Rnf4 is a growth inhibitor expressed in germ cells but not in human testicular tumors 41
Activation of RET oncogene and thyroid carcinogenesis 41
Critical role of the HMGA2 gene in pituitary adenomas. 41
NCOA4 inhibits initiation of DNA replication to maintain genome stability 41
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 41
The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity 41
Translational regulation of a novel testis-specific RNF4 transcript. 40
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization 40
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 40
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 39
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. 39
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. 39
CBX7 is a tumor suppressor in mice and humans. 39
Association between the expression of E1A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells 38
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice 38
CDH-16 gene expression in thyroid cell differentiation and transformation 38
Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. 38
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. 38
A mutated p53 gene alters thyroid cell differentiation 38
NCOA4 transcriptional coactivator inhibits activation of DNA replication origins. 38
High mobility group a proteins as tumor markers 38
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. 37
FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. 37
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 37
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. 37
The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affaected by familial medullary thyroid carcinoma. 37
Experimental thyroid carcinogenesis by RNA tumor viruses 37
Upregulation of miR-21 by Ras in vivo and its role in tumor growth 37
Molecular cloning of PTC,a new oncogene found activated in human thyiroid papillary carcinomas and their lymph node metastates 37
Critical role of HMGA proteins in regulation of ATM expression and in cellular response to DNA damage. 37
A TSH-CREB1-microRNA loop is required for thyroid cell growth. 37
Mitogenic and dedifferentiating effect of the K-fgf/hst oncogene on rat thyroid PC clone 3 epithelial cells. 36
Totale 4.653
Categoria #
all - tutte 56.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201951 0 0 0 0 0 0 0 0 0 0 7 44
2019/20201.688 669 19 154 16 192 10 16 62 5 88 212 245
2020/20211.868 18 149 268 158 172 300 153 10 185 47 311 97
2021/20222.728 40 0 1 15 24 98 31 89 632 169 516 1.113
2022/20233.457 599 266 74 410 357 409 4 305 546 301 140 46
2023/20241.392 96 314 277 136 88 161 49 229 10 32 0 0
Totale 13.530